(Q45509921)

14 December 2017

title

What is the clinical impact of occult hepatitis B virus infection? (English)

1 reference

14 December 2017

1 reference

2

1 reference

14 December 2017

Giovanni Raimondo

1

1 reference

14 December 2017

Giovanni Squadrito

series ordinal

3

1 reference

14 December 2017

language of work or name

English

0 references

publication date

1 February 2005

1 reference

14 December 2017

1 reference

14 December 2017

volume

365

1 reference

14 December 2017

issue

9460

1 reference

14 December 2017

page(s)

638-640

1 reference

Viral genetic variation: hepatitis B virus as a clinical example

14 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917961-6

7 January 2021

Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely "occult"?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917961-6

7 January 2021

Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917961-6

7 January 2021

Expansion and contraction of the hepatitis B virus transcriptional template in infected chimpanzees

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917961-6

7 January 2021

Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917961-6

7 January 2021

Occult hepatitis B virus infection in a North American adult hemodialysis patient population

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917961-6

7 January 2021

Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917961-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917961-6

1 reference

7 January 2021

Occult hepatitis B virus infection and liver disease: fact or fiction?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917961-6

7 January 2021

Occult hepatitis B virus infection: implications in transfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917961-6

7 January 2021

"Occult" hepatitis B virus as source of infection in liver transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917961-6

7 January 2021

Hepatitis B virus reactivation or reinfection associated with HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917961-6

7 January 2021

Recurrence of hepatitis B in children with serologic evidence of past hepatitis B virus infection undergoing antileukemic chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917961-6

7 January 2021

Latent hepatitis B virus infection in healthy individuals with antibodies to hepatitis B core antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917961-6

7 January 2021

High incidence of hepatitis B infections among chronic hepatitis cases of unknown aetiology

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917961-6

7 January 2021

Molecular bases for the development of hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917961-6

7 January 2021

10.1016/S0140-6736(05)17961-6

Identifiers

DOI

1 reference

14 December 2017

1 reference